about
MMR vaccination and disease elimination: the Finnish experience.Enzyme-linked immunospot assay detection of mumps-specific antibody-secreting B cells as an alternative method of laboratory diagnosisBiological feasibility of measles eradicationIntramuscular immunization of mice with live influenza virus is more immunogenic and offers greater protection than immunization with inactivated virusTransport networks and inequities in vaccination: remoteness shapes measles vaccine coverage and prospects for elimination across Africa.The role of vaccination coverage, individual behaviors, and the public health response in the control of measles epidemics: an agent-based simulation for California.Children and Adolescents Unvaccinated Against Measles: Geographic Clustering, Parents' Beliefs, and Missed Opportunities.Texas and Its Measles Epidemics.The Effect of Contact Investigations and Public Health Interventions in the Control and Prevention of Measles Transmission: A Simulation StudyHealthcare Workers and Post-Elimination Era Measles: Lessons on Acquisition and Exposure Prevention.High Concentrations of Measles Neutralizing Antibodies and High-Avidity Measles IgG Accurately Identify Measles Reinfection Cases.Health care-associated measles outbreak in the United States after an importation: challenges and economic impact.Measles elimination: progress, challenges and implications for rubella control.Long-term transmission of measles virus in Central and continental Western Europe.The impact of epidemics of vaccine-preventable disease on vaccine uptake: lessons from the 2011-2012 US pertussis epidemic.Public Health and Economic Consequences of Vaccine Hesitancy for Measles in the United States.Measles Outbreak - Minnesota April-May 2017.Vaccine technologies: From whole organisms to rationally designed protein assemblies.Global Transmission Dynamics of Measles in the Measles Elimination EraEvolution and Use of Dynamic Transmission Models for Measles and Rubella Risk and Policy Analysis.Target analysis of the experimental measles therapeutic AS-136AA measles outbreak in Sindh, Pakistan caused by a genotype B3 virus.The importance of immunization in cancer prevention, treatment, and survivorship.Measles Outbreak Among Previously Immunized Healthcare Workers, the Netherlands, 2014.Measles virus IgG avidity assay for use in classification of measles vaccine failure in measles elimination settings.Modeling Measles Transmission in the North American Amish and Options for Outbreak Response.Outbreak of measles among persons with prior evidence of immunity, New York City, 2011.Voluntary to mandatory: evolution of strategies and attitudes toward influenza vaccination of healthcare personnel.A Case of Early Onset Subacute Sclerosing Panencephalitis Presented as Juvenile Myoclonic Epilepsy.Effectiveness of Measles Vaccination and Immune Globulin Post-Exposure Prophylaxis in an Outbreak Setting-New York City, 2013.
P2860
Q30226989-03A1D5D2-1109-4A5A-93AD-597F4670F719Q30431538-DEED0EF4-3B80-4369-B23E-D5838DB371CBQ35038217-58876D43-9D79-4974-BA68-DE6D6E9A1DF9Q35068396-502A3D4B-D92C-4BAD-8AF5-44AD6D5D71D2Q35544268-45E7589D-C7BD-4B69-9890-45617451B0B2Q35619149-FECC7081-7C03-4344-9A08-7E52849695F7Q35930693-50081ED9-9A95-493A-84C3-49B8D1B38C2BQ36174015-A4F14AB6-BF58-4D53-B2DC-7EB89A1C54AAQ36219915-CF33B1FB-34EF-4009-AAAE-9F0DFEA66846Q36492389-409C9123-2D18-42FA-9577-613029767B67Q37163702-A2D1ECBC-FB01-42AE-BB2D-11AB5269BB92Q37870581-F0111051-44D2-4EC0-A30B-FF7C11AEC262Q38132267-1EC1B263-4C35-4FDA-86E8-E90FE76AF48BQ38348440-3FFE0722-4284-407F-BF94-791196185886Q38420571-2A879787-A13C-4AD8-BEC6-DDFF10ADF34BQ38664712-13D7060F-BC84-4F14-811C-FC80FEAA01BBQ38680926-7E1285BE-6CDD-468F-91A4-DB8AF890A78DQ38806558-54599BD9-AFF4-4BB2-93E7-CF29784A41C9Q38831788-9AC135C8-43C7-445E-9714-C2FF8D0C298FQ38859172-132F90D0-1B96-40B3-8C53-DA91ECAF0DCFQ39837627-2F31BE9B-1B9B-4190-89FF-1DB4585F5E08Q40084807-1A770196-3BB1-4038-9EFB-CF14033F96B3Q40104207-EAE79F95-0005-4148-8309-07DE8969CDD6Q40421196-E7F6A53F-03A3-4B39-9FDE-153AA3E314F2Q41427019-E65AE8DC-1CDD-4549-984B-2E3B419152A0Q41647797-76C0D1BC-B8D4-4A4B-A22E-D302D17D3662Q42226296-B2F59BCE-8BDB-4836-9003-575C8487A607Q46729353-5F173652-FD7F-4A6C-851C-EDE5FC292352Q47153935-E0218DD4-14D3-47CD-919B-17E7C5D89DC8Q47598102-C0321266-23AC-45E8-AF8C-97719476B329
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Measles elimination in the United States.
@ast
Measles elimination in the United States.
@en
Measles elimination in the United States.
@nl
type
label
Measles elimination in the United States.
@ast
Measles elimination in the United States.
@en
Measles elimination in the United States.
@nl
prefLabel
Measles elimination in the United States.
@ast
Measles elimination in the United States.
@en
Measles elimination in the United States.
@nl
P356
P1476
Measles elimination in the United States.
@en
P2093
Mark J Papania
Melinda E Wharton
P356
10.1086/377693
P407
P478
189 Suppl 1
P577
2004-05-01T00:00:00Z